FDA Investigator Edwin Melendez

Edwin Melendez has conducted inspections on 33 sites in 14 countries as of 20 Sep 2010. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
33
Last Inspection Date:
20 Sep 2010
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
China, Belgium, Spain, United States of America, Italy, United Kingdom of Great Britain and Northern Ireland, India, Mexico, Ireland, Israel, Portugal, Korea (Republic of), Singapore, Sweden
FDA Investigators that have inspected at least one site in common with Edwin Melendez:
Ademola O Daramola, Alexander M Kay, Amir Alavi, Anastasia M Shields, Andrew O Ejiofor, Andria L Kuhlman, Angela E Glenn, Anissa M Cheung, Anissa M Vargas, Anita Narula, PhD, Anita R Michael, Anthony A Charity, Ashar P Parikh, Astrida B Mattson, Azza Talaat, Bapu R Gaddam, Barbara Janine Breithaupt, Barbara M Frazier, Bernice F Hirsch, Bonita S Chester, Bradley Dworak, PhD, Brooke K Higgins, Brooke K Seeman, Bruce H Mccullough, Burnell M Henry, Carla J Lundi, Carole L Jones, Caryn M Mcnab, Catherine J Laufmann, CDR Rochelle B Young, RPh, MSA, Charisse K Green, Charles I Ann, Charles R Cote, RIC, Christian D Lynch (CDL), Christine A Harman, PhD, Christopher S Keating, Chryste D Best, Colleen F Hoyt, Concepcion Cruz, Jr, Connie P Rezendes, Connie R Kiessling, Constance Y Fears, Corey K Reno, Cynthia J Lee, MS, Dandan Wang, PhD, Daniel R Tammariello, David J Hafner, David K Lau, David M Beltran, Dawn E Barkans, Deborah A Greco, Debra L Pagano, Dell S Moller, Demario L Walls, Denise M Digiulio, Dennis Cantellops Paite, Diane T Bargo, Diane T O'brien, Dipesh K Shah, Dolores E Price, Don H Bark, PhD, Dr. Guang Gao, PhD, Edmund F Mrak, Jr, Eileen A Liu, Elizabeth Ll Edwards, Emest F Bizjak, Farhana Khan, Felix Maldonado, Francis A Guidry, Frederick F Razzaghi, George R Smith, Gerald B Seaborn, Jr, Gerard Pde Leon, Gerardo Z Vazquez, German Rivera, Gloria E Parra, Gloria J Baca, MS, Gwyn G Dickinson, Haitao Li, Hasan A Irier, PhD, Heika R Bounds, Heika R Tait, Heriberto Negron Rivera, Ivis L Negron, Jacqueline Mdiaz Albertini, James C Maclaughlin, Janete F Guardia, Jeffery A Hangartner, Jeffrey P Raimondi, Jennifer L Bridgewater, Jennifer L Gustavus, Jennifer M Gogley, Jocelyn E Massey, Joey V Quitania, Jonah S Ufferfilge, Jonathan G Matrisciano, Jonathan W Chapman, Jonee J Mearns, Jorge L Guadalupe, Jose A Lopez, Jose Acruz Gonzalez, José E Meléndez, Jose M Cayuela, Jose R Hernandez, Joseph J Vannelli, Joshua P Wireman, Julianne C Mccullough, Junho Pak, Justin A Boyd, Kari M Johansen, Karl D Hezel, Katherine Szestypalow, Kathryn A Krentz, Katie L Penno, Kellia N Hicks, Kenneth O Gee, PhD, Kent C Faul, Kevin A Gonzalez, Kevin D Kallander, Kevin P Foley, Kham Phommachanh, Kristen D Evans, Kristin M Abaonza, Kumar G Janoria, Larry K Austin, Laura Fontan, MS, Laurel A Beer, Laurissa S Flowers, LCDR Anastasia M Piliafas Brown, LCDR Debra Emerson, Leonard H Lavi, Lequita M Mayhew, Lewis K Antwi, Li Hongpaul Yeh, PhD, Libia M Lugo, Linda R Kuchenthal, Linda Thai, Lindsey M Schwierjohann, Lisa Hayka, Lisa K Capron, Lisa M Bellows, Lori S Lawless, Luis A Dasta, Luis Mburgos Medero, Lynda L Perry, PhD, Marcellinus D Dordunoo, Margaret A Smithers, Margaret M Annes, Margarita Santiago, Maria Pkelly Doggett, MBA, Marie F Morin, Marijo B Kambere, PhD, Marion Michaelis, Mariza M Jafary, Mark W Babbitt, Marvin D Jones, Marybet Lopez Negron, Matthew B Casale, Maxine H Wong, Maya M Davis, Megan A Haggerty, Meisha R Sampson, Meisha Waters, Melissa D Ray, Melissa J Garcia, Merideth K Rose, Michael A Taylor, Michael E Maselli, Michael L Casner, Michael R Goga, Michele L Obert, Miguel A Martinez Perez, Mihaly S Ligmond, Mikel T Wright, Mohsen Rajabi Abhari, FDA, Mra B Kamberem, Mra Davism, Mra M Barbosar, Mra Mcculloughj, Mra Munizn, Mra Narulaa, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Nancy F Scheraga, Nancy L Rolli, Nebil A Oumer, Nerizza B Guerin, Nicholas A Violand, Nicole E Knowlton, Noreen Muñiz, Norman Wong, Omotunde O Osunsanmi, Parul M Patel, Patricia A Mcilroy, Patricia A Morrow, Patricia D Stahnke, Patrick C Klotzbuecher, Paul A Bonneau, Paul L Figarole, Jr, Paula A Trost, Peter E Baker, Philip F Istafanos, DMV, MS, Prabhu P Raju, Rachael A Moliver, Rachel C Harrington, Rafael E Arroyo, Ralph A Erickson, Ralph H Vocque, Randy L Self, Raquel Gonzalez Rivera, Rebecca Rodriguez, Robert D Tollefsen, Robert J Martin, Robert M Barbosa, Robert R Wilson, Rochelle K Kimmel, Rose Xu, Rozelle G Smith, S Lori Brown, PhD MPH, Salvatore N Randazzo, Samantha J Bradley, Sandra A Hughes, Sangeeta M Khurana, PhD, Sangeeta M Rataul, Satheesh Thomas, Scott T Ballard, Seneca D Toms, Sharon K Thoma, PharmD, Shirley J Berryman, Shirshendu K Deb, PhD, Shusheen A Alexander, Simone E Pitts, Steven A Gonzales, Steven C Madzo, Steven M Weinman, Steven P Donald, Susan F Laska, MS, Susan M Jackson, Susan P Bruederle, Susan T Hadman, Suzanne M Healy, Suzanne M Muchene, Syeda N Mahazabin, Tajah L Blackburn, Ted L Anderson, Terri L Dodds, Thomas J Arista, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Timothy T Kapsala, Tina S Roecklein, Tracey L Harris, Tracy K Li, Unnee Ranjan, Uttaniti Limchumroon (Tom), Vien Q Le, Vipulchandra N Dholakia, Virgilio F Pacio, CSO, Vlada Matusovsky, Wayne E Seifert, William J Leonard, Xiaokuang Lai, PhD, Xiomara Copeland, Yumi J Hiramine, Yvesna C Blaise, Yvette I Johnson, Yvins Dezan, Zachary A Bogorad, Zachary L Miller, Zhong Li, PhD, Zhongren Wu, Zi Qiang Gu

Edwin Melendez's Documents

Publish Date Document Type Title
October, 2006 EIR Glaxo Wellcome Manufacturing Pte. Ltd - EIR, 2006-10-26
March, 2003 FDA 483 Dr Reddy's Laboratories Limited - Form 483, 2003-03-06
May, 2005 FDA 483 EUMEDICA PHARMACEUTICALS INDUSTRIES SOCIEDAD LIMITADA - Form 483, 2005-05-16
March, 2004 FDA 483 HIKMA FARMACEUTICA (PORTUGAL), S.A - Form 483, 2004-03-31
May, 2005 EIR Eurofins Biopharma Product Testing Ireland Limited - EIR, 2005-05-06
January, 2008 FDA 483 Fresenius Kabi AB - Form 483, 2008-01-30
May, 2005 FDA 483 Response Eurofins Biopharma Product Testing Ireland Limited - Form 483R, 2005-07-14
March, 2003 FDA 483 Response Dr. Reddy's Laboratories Limited (Unit II) - Form 483R, 2003-03-28
November, 2003 FDA 483 Norton Healthcare Limited - Form 483, 2003-11-04
May, 2005 FDA 483 Response EUMEDICA PHARMACEUTICALS INDUSTRIES SOCIEDAD LIMITADA - Form 483R, 2005-07-27
September, 2010 FDA 483 Teva Pharmaceutical Industries Ltd. - Form 483, 2010-09-16
May, 2005 EIR EUMEDICA PHARMACEUTICALS INDUSTRIES SOCIEDAD LIMITADA - EIR, 2005-05-17
October, 2005 FDA 483 INDOCO REMEDIES LIMITED - Form 483, 2005-10-31
May, 2005 FDA 483 Response Glaxo Operations UK Ltd - Form 483R, 2005-05-17
October, 2005 EIR Saraca Laboratories Limited - EIR, 2005-10-19
January, 2008 EIR Fresenius Kabi AB - EIR, 2008-01-30
October, 2005 EIR INDOCO REMEDIES LIMITED - EIR, 2005-10-31
March, 2003 EIR Dr. Reddy's Laboratories Limited (Unit II) - EIR, 2003-03-06
March, 2003 EIR Dr Reddy's Laboratories Limited - EIR, 2003-03-04
May, 2009 FDA 483 Jubilant HollisterStier LLC - Form 483, 2009-05-08
May, 2005 FDA 483 Glaxo Operations UK Ltd - Form 483, 2005-05-03
May, 2005 EIR Glaxo Operations UK Ltd - EIR, 2005-05-03
March, 2003 FDA 483 Response Dr Reddy's Laboratories Limited - Form 483R, 2003-06-06
January, 2008 FDA 483 Response Fresenius Kabi AB - Form 483R, 2008-02-20
October, 2005 FDA 483 Response INDOCO REMEDIES LIMITED - Form 483R, 2005-11-21
August, 2006 FDA 483 Bell-More Labs Inc - Form 483, 2006-08-17

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more